Nicotinamide mononucleotide, a potential future treatment in ocular diseases.

Deokho LeeYohei TomitaAri ShinojimaNorimitsu BanShintaro YamaguchiKen NishiokaKazuno NegishiJun YoshinoToshihide Kurihara

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2023)

Our current review suggests and discusses new modes of actions of NMN for the prevention of and protection from various ocular diseases and can urge future research to obtain more solid evidence on a potential future NMN treatment in ocular diseases at the preclinical stages.

Keyphrases

current status
stem cells
human health
risk assessment
mesenchymal stem cells
cell therapy
climate change